Rare diseases
Investigational molecules
Locations
500 Rutherford Avenue, 02129-1647, United States
Solid Biosciences Inc. focuses on neuromuscular disease research, with activity centered on Duchenne muscular dystrophy and the development of gene therapy approaches aimed at restoring microdystrophin expression in muscle tissue.
The sponsor’s clinical research interest is concentrated on treatment strategies for the genetic basis of Duchenne muscular dystrophy, with emphasis on skeletal muscle function and disease-related protein restoration.
Solid Biosciences Inc. runs clinical trials in conditions such as Duchenne muscular dystrophy, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Italy
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
